SCHEMBL4982265

SCHEMBL4982265

COCCCOc1ccnc(CS(=O)(=O)c2nc3cc(OC(F)F)ccc3[nH]2)c1C.[NaH]

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
WDR5 P61964 2/20 0.58
KMT2A Q03164 2/20 0.58
ATP4A P20648 13/20 0.46
ATP4B P51164 13/20 0.46
ATP1A1 P05023 8/20 0.46
ATP1B1 P05026 8/20 0.46
ATP1A3 P13637 8/20 0.46
ATP1B2 P14415 8/20 0.46
ATP1A2 P50993 8/20 0.46
ATP1B3 P54709 8/20 0.46
FXYD2 P54710 8/20 0.46
ATP1A4 Q13733 8/20 0.46
CYP2C9 P11712 4/20 0.44
DDAH1 O94760 2/20 0.44
ALDH1A1 P00352 2/20 0.44
LMNA P02545 2/20 0.44
MAPT P10636 2/20 0.44
HPGD P15428 2/20 0.44
ADRA1A P35348 2/20 0.44
FASN P49327 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23988304 0.99 WDR5 (0.59) WDR5KMT2AATP4AATP4BATP1A1
SCHEMBL4988421 0.98 WDR5 (0.58) WDR5KMT2AATP4AATP4BATP1A1
SCHEMBL23988519 0.89 CYP2C9 (0.53) WDR5KMT2AATP4AATP4BATP1A1
SCHEMBL23988512 0.89 ATP4A (0.56) WDR5KMT2AATP4AATP4BATP1A1
SCHEMBL23988603 0.89 KMT2A (0.47) WDR5KMT2AATP4AATP4BATP1A1
SCHEMBL23988481 0.86 ATP4A (0.45) WDR5KMT2AATP4AATP4BATP1A1
SCHEMBL6600434 0.83 KMT2A (0.62) WDR5KMT2AATP4AATP4BATP1A1
SCHEMBL538298 0.82 ATP4A (0.56) WDR5KMT2AATP4AATP4BATP1A1
SCHEMBL30102856 0.82 ATP4A (0.56) WDR5KMT2AATP4AATP4BATP1A1
SCHEMBL1307379 0.82 KMT2A (0.63) WDR5KMT2AATP4AATP4BATP1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080070942-A1 PRAZOLE DERIVATIVES AND SALTS THEREOF AND USE OF SAME JIANGSU HANSEN PHARMACEUTICAL CO., LTD. (CN) 2008-03-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080070942-A1 PRAZOLE DERIVATIVES AND SALTS THEREOF AND USE OF SAME SLC10A2, GIPR, CACNA1E WDR5 2930/4885KMT2A 2743/4885ATP4A 28/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.